InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the detailed record of transactions filed by HSIAO JANE PH D, Chief Technology Officer. Officer active across 2 companies, notably Asensus Surgical, INC.. Cumulatively, 4 filings have been published. Total volume traded: €64. The latest transaction was filed on 9 August 2021 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€3210 shares@ €3.17760.0000% mcap100.0% of flow
Common Stock
SEC:0001209191-21-050591·
Ideal exit: 6 May 2022 (T+270)
€3210 shares@ €3.17760.0000% mcap50.0% of flow
Common Stock
SEC:0001209191-21-050591:0·
Ideal exit: 6 May 2022 (T+270)
029,231 shares0
Common Stock
SEC:0001209191-21-045178·
029,231 shares0
Common Stock
SEC:0001209191-21-045178:0·
4 of 4 declarations
About HSIAO JANE PH D
Jane Hsiao, Ph.D. is the Vice Chairman & CTO at ASENSUS SURGICAL, INC. and OPKO HEALTH, INC. In these roles, she is responsible for the technical direction and innovation of the companies. Hsiao brings valuable expertise in research and development, contributing to advancements in medical technologies. Her commitment to innovation and improving patient care is essential in guiding ASENSUS and OPKO's projects. She collaborates with research teams to ensure the success of technological initiatives.
